Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Recordati

Capitalization 958.59Cr 1.11TCr 865.33Cr 830.3Cr 1.51TCr 1,02200Cr 1.58TCr 10TCr 4.1TCr 49TCr 4.17TCr 4.08TCr 1,75200Cr P/E ratio 2025 *
21x
P/E ratio 2026 * 18.5x
Enterprise value 1.15TCr 1.33TCr 1.04TCr 995.26Cr 1.81TCr 1,22500Cr 1.9TCr 12TCr 4.91TCr 59TCr 5TCr 4.9TCr 2,10100Cr EV / Sales 2025 *
4.39x
EV / Sales 2026 * 4.05x
Free-Float
46.81%
Yield 2025 *
3.07%
Yield 2026 * 3.33%
1 week-3.22%
Current month-3.22%
1 month-0.72%
3 months-4.56%
6 months-13.46%
Current year-3.46%
1 week 46.76
Extreme 46.76
48.38
1 month 46.76
Extreme 46.76
49.02
Current year 45.9
Extreme 45.9
50.05
1 year 43.98
Extreme 43.98
55.35
3 years 37.78
Extreme 37.78
60.95
5 years 34.52
Extreme 34.52
60.95
10 years 21.23
Extreme 21.23
60.95
Manager TitleAgeSince
Chief Executive Officer 63 01/12/2021
Director of Finance/CFO 56 01/01/2026
Chief Tech/Sci/R&D Officer 56 01/10/2023
Director TitleAgeSince
Chairman 54 01/12/2021
Chairman 56 12/06/2018
Director/Board Member 52 12/06/2018
Change 5d. change 1-year change 3-years change Capi.($)
0.00%-3.22%-12.49%+19.24% 1.11TCr
+0.72%-5.86%+13.89%+216.87% 88TCr
+0.32%-3.23%+44.22%+57.17% 58TCr
-0.96%-0.85%+7.38%+53.82% 41TCr
-2.93%-7.03%+11.14%+28.39% 35TCr
-1.25%-5.55%+22.14%+56.82% 30TCr
-1.85%-6.70%+20.11%+33.99% 30TCr
-0.24%-6.49%+22.33%+6.94% 29TCr
+0.53%-4.80%+13.75%+61.77% 20TCr
-0.83%-3.37%+22.59%+79.46% 18TCr
Average -0.65%-4.71%+16.51%+61.44% 35TCr
Weighted average by Cap. -0.47%-4.86%+20.17%+89.41%

Financials

2025 *2026 *
Net sales 262.03Cr 303.91Cr 236.54Cr 226.96Cr 413.87Cr 28TCr 433.13Cr 2.8TCr 1.12TCr 13TCr 1.14TCr 1.12TCr 48TCr 278.42Cr 322.92Cr 251.33Cr 241.16Cr 439.75Cr 30TCr 460.22Cr 2.97TCr 1.19TCr 14TCr 1.21TCr 1.19TCr 51TCr
Net income 49Cr 57Cr 44Cr 43Cr 78Cr 5.25TCr 81Cr 525.56Cr 210.55Cr 2.52TCr 214.38Cr 209.81Cr 9TCr 57Cr 66Cr 52Cr 50Cr 90Cr 6.1TCr 95Cr 611.12Cr 244.83Cr 2.93TCr 249.28Cr 243.96Cr 10TCr
Net Debt 190.44Cr 220.88Cr 171.91Cr 164.95Cr 300.79Cr 20TCr 314.8Cr 2.03TCr 814.18Cr 9.73TCr 828.98Cr 811.31Cr 35TCr 170.27Cr 197.49Cr 153.71Cr 147.49Cr 268.94Cr 18TCr 281.46Cr 1.82TCr 727.96Cr 8.7TCr 741.19Cr 725.39Cr 31TCr
Logo Recordati
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (64.4%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (35.6%). Net sales are distributed geographically as follows: Italy (14.3%), Europe (56.1%), America (20.4%), Asia and Oceania (6.7%) and Africa (2.5%).
Employees
4,539
Date Price Change Volume
06/26/06 46.86 -1.51% 2,89,331
05/26/05 47.58 -0.92% 3,12,269
04/26/04 48.02 +0.13% 3,15,450
03/26/03 47.96 +1.35% 5,25,660
02/26/02 47.32 -2.27% 3,42,611
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
46.86EUR
Average target price
59.12EUR
Spread / Average Target
+26.17%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW